Figure 2.
Consolidated Standards of Reporting Trials (CONSORT) diagram of the patients studied. This includes the total number of patients seen in the TOP MDC and the subsets further studied for feasibility, prevalence of vulnerabilities, and outcomes. alloSCT, allogeneic stem cell transplant; autoSCT, autologous stem cell transplant; CAR, chimeric antigen receptor.